A large survey found elevated ALT in 8 % of U.S. adolescents [267], whereas in the two largest samples of biopsy-proven NAFLD, NASH was diagnosed in 64-84% of NAFLD children in Italy and California [268, 269]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.